HGH (Somatropin) vs LL-37
Updated September 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of HGH (Somatropin) and LL-37 (also searched as LL-37 vs HGH (Somatropin)) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
HGH (Somatropin) centers on muscle, while LL-37 leans toward healing. On indexed research, HGH (Somatropin) is ahead (HGH (Somatropin): 55 studies, Human clinical; LL-37: 32, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •HGH (Somatropin) is strongest for muscle; LL-37 for healing.
- •Evidence: HGH (Somatropin) Human clinical (55 studies) vs LL-37 Human evidence (32).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
Growth stimulation | Growth hormone deficiency
HGH (Somatropin) vs LL-37: side-by-side
| Metric | HGH (Somatropin) | LL-37 |
|---|---|---|
| Class | Healing | Immune |
| Regulatory status | FDA-approved | Research use only |
| Evidence grade | Human clinical | Human evidence |
| Studies indexed | 55 | 32 |
| Research level | FDA Approved | Well Studied |
| Strongest effect | Muscle & body comp | Healing & recovery |
| Healing & recovery | 4.0▲ | 4.0▲ |
| Muscle & body comp | 5.0▲ | 1.0 |
| Metabolic & appetite | 4.0▲ | 2.0 |
| Neuro & mood | 2.0▲ | 1.0 |
| Sleep & circadian | 2.0▲ | 0.0 |
| Inflammation & immune | 3.0 | 4.0▲ |
| Skin & aesthetics | 4.0▲ | 2.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | HGH (Somatropin) | LL-37 |
|---|---|---|
| Mechanism | IGF-1 activation | Disrupts microbial membranes, leading to cell lysis |
| Route | Subcutaneous injection | — |
| Half-life | ~20 min | — |
| Time to peak | 3–6 hours | — |
| Duration of action | variable | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is HGH (Somatropin)?
HGH (somatropin) is recombinant human growth hormone, FDA-approved for pediatric and adult GH deficiency and several wasting and short-stature conditions; widely studied for body composition off-label.
Full HGH (Somatropin) profile, mechanism & studies →What is LL-37?
LL-37 is a human cathelicidin antimicrobial peptide that plays a significant role in the innate immune response. It exhibits a range of biological activities, including antimicrobial, immunomodulatory, and wound healing properties. LL-37 is produced by various cells, including epithelial cells and neutrophils, and is known to interact with a variety of pathogens, including bacteria, viruses, and fungi.
Full LL-37 profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~4.0/5 |
| Muscle | HGH (Somatropin) | 5.0/5 effect signal |
| Metabolic | HGH (Somatropin) | 4.0/5 effect signal |
| Neuro | HGH (Somatropin) | 2.0/5 effect signal |
| Sleep | HGH (Somatropin) | 2.0/5 effect signal |
| Inflammation | LL-37 | 4.0/5 effect signal |
| Skin | HGH (Somatropin) | 4.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack HGH (Somatropin) and LL-37?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
HGH (Somatropin) vs LL-37: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
HGH (Somatropin) has 55 approved studies indexed (Human clinical), and LL-37 has 32 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is HGH (Somatropin) or LL-37 better?
It depends on your goal. HGH (Somatropin) is strongest for muscle; LL-37 for healing. HGH (Somatropin) has more indexed studies (55). See the goal-by-goal breakdown above.
Is HGH (Somatropin) or LL-37 better for weight loss?
HGH (Somatropin) shows the stronger metabolic & appetite profile (4.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is HGH (Somatropin) or LL-37 better for muscle?
HGH (Somatropin) leads on the muscle & body-composition axis (5.0/5).
Which has more research, HGH (Somatropin) or LL-37?
HGH (Somatropin) has 55 approved studies indexed (Human clinical); LL-37 has 32 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack HGH (Somatropin) and LL-37?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of HGH (Somatropin) vs LL-37?
HGH (Somatropin): no community-reported effects logged yet. LL-37: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is HGH (Somatropin) or LL-37 FDA-approved?
HGH (Somatropin) is FDA-approved. LL-37 is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is LL-37 better than HGH (Somatropin)?
For healing, LL-37 has the edge; for muscle, HGH (Somatropin) does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 21, 2026.